Study aims to cut down on eye injections for vision loss
NCT ID NCT00527475
Summary
This study tested if combining a light-based therapy with a standard eye injection could reduce the number of injections needed to treat wet age-related macular degeneration (AMD). It involved 60 people with this condition, comparing the standard injection schedule to a combined treatment approach. The goal was to control the disease while lowering the risks and burden of frequent eye injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Associated Retinal Consultants
Ann Arbor, Michigan, 49301, United States
-
California Retina Consultants & Research Foundation
Santa Barbara, California, 93103, United States
-
Texas Retina Associates
Arlington, Texas, 76012, United States
Conditions
Explore the condition pages connected to this study.